Venture Life Group (VLG) Competitors GBX 58 -1.00 (-1.69%) As of 07/11/2025 11:38 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock VLG vs. ANCR, DNL, EAH, STX, PXS, CHLL, MXC, RGT, CEL, and N4PShould you be buying Venture Life Group stock or one of its competitors? The main competitors of Venture Life Group include Animalcare Group (ANCR), Diurnal Group (DNL), ECO Animal Health Group (EAH), Shield Therapeutics (STX), Provexis (PXS), Chill Brands Group (CHLL), Argent BioPharma (MXC), Argent BioPharma (RGT), Celadon Pharmaceuticals (CEL), and N4 Pharma (N4P). These companies are all part of the "drug manufacturers - specialty & generic" industry. Venture Life Group vs. Its Competitors Animalcare Group Diurnal Group ECO Animal Health Group Shield Therapeutics Provexis Chill Brands Group Argent BioPharma Argent BioPharma Celadon Pharmaceuticals N4 Pharma Animalcare Group (LON:ANCR) and Venture Life Group (LON:VLG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk. Do institutionals & insiders have more ownership in ANCR or VLG? 49.0% of Animalcare Group shares are owned by institutional investors. Comparatively, 69.5% of Venture Life Group shares are owned by institutional investors. 29.5% of Animalcare Group shares are owned by company insiders. Comparatively, 10.4% of Venture Life Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is ANCR or VLG more profitable? Animalcare Group has a net margin of 43.05% compared to Venture Life Group's net margin of 1.44%. Animalcare Group's return on equity of 36.62% beat Venture Life Group's return on equity.Company Net Margins Return on Equity Return on Assets Animalcare Group43.05% 36.62% 2.97% Venture Life Group 1.44%0.99%1.56% Does the media refer more to ANCR or VLG? In the previous week, Venture Life Group's average media sentiment score of 0.67 beat Animalcare Group's score of 0.00 indicating that Venture Life Group is being referred to more favorably in the news media. Company Overall Sentiment Animalcare Group Neutral Venture Life Group Positive Which has preferable earnings and valuation, ANCR or VLG? Animalcare Group has higher revenue and earnings than Venture Life Group. Animalcare Group is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnimalcare Group£84.90M2.36£36.55M£53.645.44Venture Life Group£51.77M1.43£747.21K£0.5998.43 Which has more risk and volatility, ANCR or VLG? Animalcare Group has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Venture Life Group has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. SummaryAnimalcare Group beats Venture Life Group on 9 of the 12 factors compared between the two stocks. Get Venture Life Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VLG vs. The Competition Export to ExcelMetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£73.91M£2.18B£5.56B£3.00BDividend Yield0.09%2.92%5.07%5.02%P/E Ratio98.434.1521.21150.83Price / Sales1.43562.62432.08314,599.98Price / Cash6.4010.3537.1227.97Price / Book0.9911.408.044.58Net Income£747.21K£21.15B£3.19B£5.90B7 Day Performance-4.13%0.25%3.63%11.51%1 Month Performance16.00%6.08%4.06%7.92%1 Year Performance24.57%2.39%30.02%32.01% Venture Life Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VLGVenture Life GroupN/AGBX 58-1.7%N/A+20.8%£73.91M£51.77M98.43165Positive NewsANCRAnimalcare GroupN/AGBX 292.75-0.8%N/A+24.5%£200.71M£84.90M5.46220DNLDiurnal GroupN/AN/AN/AN/A£46.33M£4.68M-3.2133EAHECO Animal Health GroupN/AGBX 60.55+0.9%N/A-54.3%£41.03M£89.44M39.14234Gap DownSTXShield TherapeuticsN/AGBX 3+5.2%N/A+91.0%£29.58M£20.92M-0.7740,000PXSProvexisN/AGBX 0.82-5.2%N/A+29.9%£19.24M£846.98K-31.094Gap DownHigh Trading VolumeCHLLChill Brands GroupN/AN/AN/AN/A£10.89M£624.19K-215.007News CoverageEarnings ReportMXCArgent BioPharmaN/AN/AN/AN/A£9.65M£1.32M-13.255Gap UpRGTArgent BioPharmaN/AN/AN/AN/A£8.31MN/A-0.65N/AGap DownHigh Trading VolumeCELCeladon PharmaceuticalsN/AGBX 13.40flatN/AN/A£8.22M£123.38K-1.682,780Gap DownN4PN4 PharmaN/AGBX 0.35-6.7%N/A-25.4%£1.51M£8.84K-1.015Gap Down Related Companies and Tools Related Companies Animalcare Group Competitors Diurnal Group Competitors ECO Animal Health Group Competitors Shield Therapeutics Competitors Provexis Competitors Chill Brands Group Competitors Argent BioPharma Competitors Argent BioPharma Competitors Celadon Pharmaceuticals Competitors N4 Pharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VLG) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get PaidBank of America believes gold could hit $4,000 an ounce in the next 12 months. That's an 18% jump from toda...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venture Life Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Venture Life Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.